Ordered hierarchy versus scale invariance in sequence stratigraphy

200 x 10(6) years) are symmetrical transgressive- regressive cycles. However, the sequence record in the range of 1 x 10(4)-200 x 10(6) years, the principal domain of sequence stratigraphy, shows a rather irregular succession of sequences with variable symmetry and bounded by flooding surfaces or exposure surfaces. For these time scales, scale-invariant models are a good first approximation, particularly because the evidence for scale-invariance and randomness in the stratigraphic record is strong: Frequency spectra of sea-level change as well as rates of sedimentation and rates of accommodation change plotted against length of observation span show basic trends indistinguishable from random walk. These trends, combined with scale-invariant sequence models may be the most efficient tools for across-the-board predictions on sequences and for locating islands of order in the sequence record

Early–middle Holocene relative sea-level oscillation events recorded in a submerged speleothem from the Yucatán Peninsula, Mexico

Geomorphological and biological archives of relative sea-level change in the western North Atlantic-Caribbean region following the Last Glacial Maximum have traditionally supported the hypothesis of a punctuated rise towards the present sea level. Such records, however, are often at insufficient resolution to discern centennial-scale changes. In caves where the water table is closely controlled by sea level, active periods of speleothem growth constraining maximum sea level, used in combination with marine overgrowths constraining minimum sea level, are a promising alternative archive recording sea-level variability at higher resolution. Here, we present a U-Th-dated early–middle Holocene speleothem record from a submerged cave on the tectonically stable Yucatán Peninsula, Mexico. Our record shows that polychaetes (Annelida, Polychaeta) colonised a sub-aerially deposited stalagmite during four individual submergence events. Submergence events occurred at approximately 8.9, 8.6, 8.4 and 6.0 ka, which we attribute to previously unrecognised minor sea-level oscillation events (OE1–OE4) above and below −6.12 ± 0.1 m relative to present sea level (r.s.l.). Combining these results with mangrove-derived relative sea-level constraints from another submerged cave on the Yucatán Peninsula, we are able to suggest that OE1 and OE2 did not reach as high as −5.26 m r.s.l., but that OE3 and OE4 exceeded −5.22 m r.s.l. We conclude that subsidence of the North American ice-load bulge was the main cause of relative sea-level rise. Superimposed on the glacio-isostatic adjustment were periods of widespread northern hemisphere cooling and ice margin re-advance, resulting in a relative sea-level fall on four occasions during the early–middle Holocene

Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses

INTRODUCTION: Intravenous (IV) injection of mesenchymal stem cells (MSCs) is used to treat systemic human diseases and disorders but is not routinely used in equine therapy. In horses, MSCs are isolated primarily from adipose tissue (AT) or bone marrow (BM) and used for treatment of orthopedic injuries through one or more local injections. The objective of this study was to determine the safety and lymphocyte response to multiple allogeneic IV injections of either AT-derived MSCs (AT-MSCs) or BM-derived MSCs (BM-MSCs) to healthy horses. METHODS: We injected three doses of 25 × 10(6) allogeneic MSCs from either AT or BM (a total of 75 × 10(6) MSCs per horse) into five and five, respectively, healthy horses. Horses were followed up for 35 days after the first MSC infusion. We evaluated host inflammatory and immune response, including total leukocyte numbers, serum cytokine concentration, and splenic lymphocyte subsets. RESULTS: Repeated injection of allogeneic AT-MSCs or BM-MSCs did not elicit any clinical adverse effects. Repeated BM-MSC injection resulted in increased blood CD8(+) T-cell numbers. Multiple BM-MSC injections also increased splenic regulatory T cell numbers compared with AT-MSC-injected horses but not controls. CONCLUSIONS: These data demonstrate that multiple IV injections of allogeneic MSCs are well tolerated by healthy horses. No clinical signs or clinico-pathologic measurements of organ toxicity or systemic inflammatory response were recorded. Increased numbers of circulating CD8(+) T cells after multiple IV injections of allogeneic BM-MSCs may indicate a mild allo-antigen-directed cytotoxic response. Safety and efficacy of allogeneic MSC IV infusions in sick horses remain to be determined

Ultrasound of the Kidney

N/